U.S., May 9 -- ClinicalTrials.gov registry received information related to the study (NCT06962306) titled 'Optimizing Perioperative Analgesia to Lower Pain Following Cleft Palate Surgery' on April 30.... Read More
U.S., May 9 -- ClinicalTrials.gov registry received information related to the study (NCT06962059) titled 'Healthy Volunteers Study' on April 10. Brief Summary: The purpose of this study is to examin... Read More
U.S., May 9 -- ClinicalTrials.gov registry received information related to the study (NCT06961942) titled 'Enhancing Endoscopic Scoring Consistency and Accuracy in IBD: a Video-based Training Approach... Read More
U.S., May 9 -- ClinicalTrials.gov registry received information related to the study (NCT06962670) titled 'Predicting Cancer Risk With Digital and Molecular Markers' on Aug. 23, 2023. Brief Summary: ... Read More
U.S., May 9 -- ClinicalTrials.gov registry received information related to the study (NCT06961500) titled 'Obinutuzumab With CHOP Versus Obinutuzumab With Bendamustine in the Treatment of Newly Diagno... Read More
U.S., May 9 -- ClinicalTrials.gov registry received information related to the study (NCT06962800) titled 'A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Pr... Read More
U.S., May 9 -- ClinicalTrials.gov registry received information related to the study (NCT06963242) titled 'Evaluating the Accuracy of Dynamic Navigation in Implant Surgery for Full Arch Prosthesis' on... Read More
U.S., May 9 -- ClinicalTrials.gov registry received information related to the study (NCT06961552) titled 'The Effect of Reflexology on Premenstrual Syndrome Symptoms, Pain and Quality of Life' on Apr... Read More
U.S., May 9 -- ClinicalTrials.gov registry received information related to the study (NCT06962813) titled 'Transdermal Radiofrequency V ERASER Versus Polidocanol Sclerotherapy for Reticular Veins and ... Read More
U.S., May 9 -- ClinicalTrials.gov registry received information related to the study (NCT06962137) titled 'Phase II RAINSPOT: Zolbetuximab-Paclitaxel-Ramucirumab for CLDN18.2 Positive Gastro-esophagea... Read More